-
11.
公开(公告)号:CZ300063B6
公开(公告)日:2009-01-21
申请号:CZ20001525
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: PHAN LY TAM , OR YAT SUN , CHU DANIEL T , PLATTNER JACOB J , CHEN YAN , CLARK RICHARD F
IPC: C07H17/08 , A61K31/7042 , A61K31/7048 , A61P31/04
Abstract: 2-Halogen-6-O-substituované ketolidové deriváty ajejich farmaceuticky prijatelné soli a estery vykazující antibakteriální aktivitu, které mají vzorec (I), prípravky obsahující terapeuticky úcinné množství slouceniny vynálezu v kombinaci s farmaceuticky prijatelným nosicem. Dále je popsán zpusob prípravy ketolidových derivátu, farmaceutická kompozice pro ošetrení bakteriálních infekcí obsahující úcinné množství uvedeného ketolidového derivátu a použití techto ketolidových derivátu.
-
公开(公告)号:BR0109946A
公开(公告)日:2005-08-02
申请号:BR0109946
申请日:2001-10-16
Applicant: ABBOTT LAB
Inventor: MA ZHENKUN , PHAN LY TAM , CLARK RICHARD F , ZHANG SOUMING , DJURIC STEVAN
IPC: A61K31/7056 , A61P31/04 , C07H17/08 , A61K31/7048
-
公开(公告)号:NZ503822A
公开(公告)日:2002-12-20
申请号:NZ50382298
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: PHAN LY TAM , OR YAT SUN , CHU DANIEL T , PLATTNER JACOB J , CHEN YAN , CLARK RICHARD F
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/7052
Abstract: A compound selected from the group consisting of (I) and (II), and pharmaceutically acceptable salts and esters thereof, wherein: RP is hydrogen or a hydroxy protecting group; X is F, Cl, Br, or I; and R1 is selected from the group consisting of: (1) Cl-C6-alkyl optionally substituted with one or more substituents selected from the group consisting of a) Aryl, b) Substituted aryl, c) Heteroaryl, d) Substituted heteroaryl, e) -NR3R4 wherein R3 and R4 are independently selected from hydrogen and Cl-C3-alkyl, or R3 and R4 are taken together with the atom to which they are attached form a 3-7 membered ring containing a moiety selected from the group consisting of-O-, -NH-, -N (CI-C6-alkyl-)-, -N (aryl-Cl-C6-alkyl-)-, -N (substituted aryl-Cl-C6-alkyl-)-, -N (heteroaryl-Cl-C6-alkyl-)-, and-N (substituted heteroaryl Cl-C6-alkyl-)- ; (2) -CH2-CH=CH-Y, wherein Y is selected from the group consisting of a) H; b) Aryl; c) Substituted aryl; d) Heteroaryl; e) Substituted heteroaryl; f) -CH=CH2; g) -CH=CH-aryl; h) -CH=CH-substituted aryl; i) -CH=CH-heteroaryl; and j) -CH=CH-substituted heteroaryl; k) (aryl) oyl; l) (substituted aryl) oyl; m) (heteroaryl) oyl; and n) (substituted heteroaryl) oyl; and (3) -CH2-C-=C-Y, wherein Y is as defined previously, with the proviso that in compounds of formula (II) wherein R1 is selected from option (1) the C1-C6-alkyl group must be substituted.
-
公开(公告)号:PE20020522A1
公开(公告)日:2002-06-25
申请号:PE2001001021
申请日:2001-10-15
Applicant: ABBOTT LAB
Inventor: MA ZHENKUN , PHAN LY TAM , ZHANG SUOMING , DJURIC STEVAN , CLARK RICHARD F
IPC: A61K31/7048 , A61K31/7056 , A61P31/04 , C07H17/08
Abstract: SE REFIERE A DERIVADOS DE ERITROMICINA (CETOLIDOS 6-O-SUSTITUIDOS) DE FORMULA I DONDE A1 ES ARILO, HETEROARILO; Y1 ES ISOXAZOL, OXAZOL, ISOTIAZOL, DIHIDROISOXAZOL, DIHIDROOXAZOL; D1 ES HC-CH; C C; R1 ES H, Rp; Rp ES UN GRUPO PROTECTOR DE OH. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS PUEDEN SER UTILES PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS SIN PRODUCIR EL EFECTO COLATERAL DE INTOLERANCIA INTESTINAL COMO NAUSEAS, VOMITOS
-
公开(公告)号:HU0004282A2
公开(公告)日:2001-04-28
申请号:HU0004282
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: CHEN YAN , CHU DANIEL T , CLARK RICHARD F , OR YAT SUN , PHAN LY TAM , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
公开(公告)号:AU2449597A
公开(公告)日:1998-08-03
申请号:AU2449597
申请日:1997-04-07
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PHAN LY TAM , CHU DANIEL T , SPINA KENNETH P , HALLAS ROBERT , ELLIOTT RICHARD L , TUFANO MICHAEL
IPC: C07H17/00 , A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/00 , A61P31/04 , C07H17/08 , A61K31/71
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of the formula:wherein A, B, D and E, R1, R2, and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:CA2277116A1
公开(公告)日:1998-07-16
申请号:CA2277116
申请日:1997-04-07
Applicant: ABBOTT LAB
Inventor: HALLAS ROBERT , PHAN LY TAM , OR YAT SUN , TUFANO MICHAEL , ELLIOTT RICHARD L , SPINA KENNETH P , CHU DANIEL T
IPC: C07H17/00 , A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/00 , A61P31/04 , C07H17/08 , A61K31/71
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulas: (I); (II); (III); or (IV); wherein A, B, D and E, R1, R2, and Z specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:CA2391297C
公开(公告)日:2009-01-06
申请号:CA2391297
申请日:2000-12-01
Applicant: ABBOTT LAB
Inventor: MA ZHENKUN , OR YAT SUN , PHAN LY TAM
IPC: C07H17/00 , A61K31/7042 , A61K31/7052 , A61K31/7056 , A61P31/04 , C07H17/08
Abstract: The present invention relates to 6-O-alkyl-2-nor-2-substituted ketolide compound or a derivative thereof, a composi-tion comprising the compound and a suitable carrier, a method of preparing the compound, and a method of treatment and prevention of in mammals comprising administering said compound.
-
公开(公告)号:ES2306674T3
公开(公告)日:2008-11-16
申请号:ES00982357
申请日:2000-12-01
Applicant: ABBOTT LAB
Inventor: PHAN LY TAM , OR YAT SUN , MA ZHENKUN
IPC: C07H17/00 , A61K31/7052 , A61K31/7056 , A61P31/04 , C07H17/08
Abstract: Un compuesto de fórmula (Ver fórmula) o una sal farmacéuticamente admisible del mismo, en donde: R P es hidrógeno o un grupo protector de hidroxi, en donde el grupo protector de hidroxi es benzoílo; R 2 se selecciona del grupo que se compone de: (a) hidrógeno, y (b) heteroarilo, en donde el heteroarilo es quinolilo o quinoxalinilo; R 3 se selecciona del grupo que se compone de: (a) hidrógeno, (b) -OH, (c) F, Cl, Br o I, (d) alquilo C1 sustituido con un sustituyente -OH, (d) alquenilo C2-C6-R 2 , y (e) alquinilo C2-C6-R 2 ; R 4 se selecciona del grupo que se compone de: (a) hidrógeno, (b) OH, y (c) F, Cl, Br o I; o R 3 y R 4 tomados juntos forman =CH2 o -CH2O-; e Y es hidrógeno.
-
公开(公告)号:DK1181299T3
公开(公告)日:2008-10-27
申请号:DK00930370
申请日:2000-05-04
Applicant: ABBOTT LAB
Inventor: MA ZHENKUN , PHAN LY TAM , CLARK RICHARD F , ZHANG SUOMING , OR YAT SUN
IPC: C07H17/08 , A61K31/70 , A61K31/7048 , A61P31/04
Abstract: A compound having the formula selected from the group consisting ofa compound of formula Ia compound of formula IIa compound of formula IIIas well as and pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptible compositions, methods of treating bacterial infections, and processes for the preparation of the compounds.
-
-
-
-
-
-
-
-
-